
January 10, 2027 (InterContinental San Francisco) — We’re pleased to announce that Josh Resnick, Partner at RA Capital, will speak at The 8th ACCESS ASIA BD Forum @ JPM 2027.
Hosted by YAFO, ACCESS ASIA builds on the success of ACCESS CHINA, expanding the platform’s reach to foster cross-border connections between Asian biotech innovators and global pharmaceutical companies, investors, and strategic partners. Taking place on January 10, 2027, at the InterContinental San Francisco, the forum will provide a global platform for Asian biotech companies to showcase their innovations, connect with potential partners, and identify new business development and collaboration opportunities. View more information at: https://biotochina.org/
About the Speaker
Josh Resnick is a Partner at RA Capital Management. Josh’s primary responsibility is to lead early-stage private investments and oversee the creation of new companies developing drugs, medical devices, diagnostics, and research tools. He has more than 15 years of experience in investing, company formation, and company leadership across all stages of drug development, from discovery through commercialization. Josh was previously co-lead of SV Health Investors’ US Biotech practice, where he was responsible for SV’s US venture creation activities, including its incubator, Brahma Discovery. Before SV, Josh was President and Managing Partner at MRL Ventures Fund, the early-stage therapeutics-focused corporate venture fund within Merck & Co. Prior to MRL Ventures, Josh was a Venture Partner with Atlas Venture and a Partner at Prism Venture Partners, focusing on company formation and seed and Series A investing. Josh is currently a faculty member at Harvard Medical School and continues to practice medicine as an attending physician in the Department of Emergency Medicine at Massachusetts General Hospital. Josh holds a BA in Chemistry from Williams College, an MD from the University of Pennsylvania School of Medicine, and an MBA from the Wharton School of Business.
About The 8th ACCESS ASIA BD Forum @ JPM 2027
The 8th ACCESS ASIA BD Forum @ JPM 2027 is scheduled to be held on January 10, 2027, at the InterContinental San Francisco.
This full-day forum will feature keynote speeches, panel discussions, corporate presentations, company showcases, and 1-on-1 partnering meetings connecting Asia’s leading biotech innovators with global pharma, investors, and strategic partners.
Date: January 10, 2027 (Sunday)
Venue: InterContinental San Francisco
View more information at: https://biotochina.org/2026/10/28/access-asia-jpm2027/

MORE INFORMATION
Contact Us
To register as an attendee for The 8th ACCESS ASIA BD Forum @ JPM 2027, please visit:
https://jsj.top/f/AqkB9m?x_field_1=Speaker+Promotion
For more information, please contact:
Wendi Xiang